TickerFacts.

Acadia Pharmaceuticals Inc (ACAD): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2014-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$93.02M
Year ended 2014-12-31
2011-12-31: -$22.57M2012-12-31: -$20.78M2013-12-31: -$38.22M2014-12-31: -$93.02M-$93.02M
2011-12-31 EBITDA (USD) 2014-12-31
Period endedEBITDAChange YoYSource filing
2014-12-31-$93.02Mn/m2017-02-28, From 2014-01-01
2013-12-31-$38.22Mn/m2016-02-29, From 2013-01-01
2012-12-31-$20.78Mn/m2015-02-26, From 2012-01-01
2011-12-31-$22.57Mn/a2014-02-27, From 2011-01-01